ALPINE IMMUNE SCIENCES, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2016 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Alpine Immune Sciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2016 to Q1 2024.
  • Alpine Immune Sciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $3.99M, a 56.3% increase year-over-year.
  • Alpine Immune Sciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $12.1M, a 21.8% increase year-over-year.
  • Alpine Immune Sciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $10.6M, a 10.2% increase from 2022.
  • Alpine Immune Sciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $9.65M, a 54.6% increase from 2021.
  • Alpine Immune Sciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $6.24M, a 50.7% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.